midazolam has been researched along with Encephalomyopathies, Mitochondrial in 3 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, T | 1 |
| Miyazawa, N | 1 |
| Yamamoto, S | 1 |
| Kawahara, H | 1 |
| Yamaguchi, S | 1 |
| Prüss, H | 1 |
| Holtkamp, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study to Assess the Efficacy of Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy[NCT05019885] | Phase 2 | 6 participants (Anticipated) | Interventional | 2022-08-26 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for midazolam and Encephalomyopathies, Mitochondrial
| Article | Year |
|---|---|
Anesthetic Management in Mitochondrial Encephalomyopathy: A Case Report.
Topics: Adjuvants, Anesthesia; Adolescent; Anesthesia, General; Dental Caries; Entropion; Humans; Male; Mida | 2017 |
[Efficacy of Dexmedetomidine in Monitored Anesthesia Care (MAC) for a Woman with Mitochondrial Encephalomyopathy Associated with Myoclonus].
Topics: Adult; Anesthesia Recovery Period; Anesthetics, Intravenous; Dexmedetomidine; Female; Humans; Midazo | 2017 |
Ketamine successfully terminates malignant status epilepticus.
Topics: Anesthesia, General; Anesthetics, Dissociative; Anticonvulsants; Coma; DNA Polymerase gamma; DNA-Dir | 2008 |